Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
15M
-
Number of holders
-
37
-
Total 13F shares, excl. options
-
5.48M
-
Shares change
-
+65.2K
-
Total reported value, excl. options
-
$30.1M
-
Value change
-
+$360K
-
Number of buys
-
12
-
Number of sells
-
-14
-
Price
-
$5.50
Significant Holders of CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) as of Q4 2016
41 filings reported holding CPIX - CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value as of Q4 2016.
CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) has 37 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.48M shares
of 15M outstanding shares and own 36.63% of the company stock.
Largest 10 shareholders include ARIEL INVESTMENTS, LLC (1.82M shares), DIMENSIONAL FUND ADVISORS LP (853K shares), Stonepine Capital Management, LLC (620K shares), BlackRock Institutional Trust Company, N.A. (382K shares), VANGUARD GROUP INC (297K shares), NEW YORK STATE COMMON RETIREMENT FUND (289K shares), BRIDGEWAY CAPITAL MANAGEMENT INC (277K shares), RENAISSANCE TECHNOLOGIES LLC (257K shares), ACADIAN ASSET MANAGEMENT LLC (126K shares), and BARD ASSOCIATES INC (92.5K shares).
This table shows the top 37 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.